Discovering, developing, and manufacturing next generation live biotherapeutics
Our state-of-the-art platform enables an unprecedented understanding of host-microbiome interaction and provides an efficient approach to drug discovery.
Visualization of host-microbiome interaction in situ
Reproducible large-scale manufacturing of complex consortia
Formulating live biotherapeutics that optimize healthy human-gut microbiome
A novel approach, from microbiome profiling to high-thoughput drug manufacturing.
A platform for discovering, developing, and manufacturing next-generation live biotherapeutics takes advantage of our foundational understanding of the microbiome, addressing all FDA requirements and accelerating critical steps along the drug development pathway.
Mapping host-microbiome interactions in situ at high resolution & multiplexity
We simultaneously identify host-cell transcripts and microbial taxonomy. By profiling host-microbiome interaction in situ, we can gain an unprecedented understanding of the microbiome for novel therapeutic development.
ACT™ Manufacturing: Anaerobic Co-culture Technology
Manufacturing consortia from purified cell lines
We co-culture communities of isolated strains at an industrial scale with our state-of-the-art production technology.
We work with partners to better understand the microbiome and its role in disease and drug candidates.
We have a vast partnership network made up of some of the top biotechnology and pharmaceutical companies in the scientific community.